PHIO
Price:
$0.9842
Market Cap:
$11.43M
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
PHIO
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.71. This represents a change of -42.33% compared to the average of -1.23 of the last 4 quarters.
The mean historical PE Ratio of Phio Pharmaceuticals Corp. over the last ten years is -0.80. The current -0.71 PE Ratio has changed 8.76% with respect to the historical average. Over the past ten years (40 quarters), PHIO's PE Ratio was at its highest in in the March 2025 quarter at -0.00. The PE Ratio was at its lowest in in the June 2021 quarter at -2.84.
Average
-0.80
Median
-0.63
Minimum
-1.98
Maximum
-0.15
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual PE Ratio = -0.15
Minimum Annual Increase = -78.05%
Minimum Annual PE Ratio = -1.98
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.72 | -63.39% |
| 2024 | -1.98 | 1.26% |
| 2023 | -0.15 | -67.45% |
| 2022 | -0.45 | -53.78% |
| 2021 | -0.97 | -30.79% |
| 2020 | -1.40 | 186.25% |
| 2019 | -0.49 | 55.40% |
| 2018 | -0.32 | -68.69% |
| 2017 | -1.01 | 87.97% |
| 2016 | -0.54 | -78.05% |
The current PE Ratio of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.95
5-year avg
-0.85
10-year avg
-0.80
Phio Pharmaceuticals Corp.’s PE Ratio is less than TransCode Therapeutics, Inc. (-0.10), greater than Kiora Pharmaceuticals, Inc. (-0.96), less than IN8bio, Inc. (-0.28), greater than BioCardia, Inc. (-0.75), less than Aprea Therapeutics, Inc. (-0.35), greater than Marker Therapeutics, Inc. (-1.66), less than Damora Therapeutics, Inc. (-0.22), less than Creative Medical Technology Holdings, Inc. (-0.33), less than Acurx Pharmaceuticals, Inc. (-0.28), less than Aptevo Therapeutics Inc. (-0.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.10 | $5.25M | |
| -0.96 | $11.39M | |
| -0.28 | $10.26M | |
| -0.75 | $4.49M | |
| -0.35 | $4.03M | |
| -1.66 | $11.99M | |
| -0.22 | $34.47M | |
| -0.33 | $1.79M | |
| -0.28 | $2.20M | |
| -0.01 | $8.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Phio Pharmaceuticals Corp.'s PE Ratio?
How is the PE Ratio calculated for Phio Pharmaceuticals Corp. (PHIO)?
What is the highest PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
What is the 3-year average PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
What is the 5-year average PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
How does the current PE Ratio for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?